Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| ARCH Venture Management, LLC | 3.25M | $45.0M | 13.88% | -- | 2026-06-30 |
| GSK plc | 1.51M | $21.0M | 6.47% | -- | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 786.8K | $11.0M | 3.36% | +68.6K | 2026-06-30 |
| Orland Properties Ltd | 754.7K | $10.0M | 3.23% | -- | 2026-06-30 |
| BlackRock, Inc. | 724.3K | $10.0M | 3.10% | +532.5K | 2026-06-30 |
| Almitas Capital LLC | 581.4K | $8.0M | 2.48% | +3.6K | 2026-06-30 |
| Foresite Capital Management V, LLC | 476.4K | $6.0M | 2.04% | -692 | 2026-06-30 |
| MILLENNIUM MANAGEMENT LLC | 367.5K | $5.0M | 1.57% | -91.4K | 2026-06-30 |
| Opaleye Management Inc. | 344.0K | $4.0M | 1.47% | +264.9K | 2026-06-30 |
| venBio Partners LLC | 337.7K | $4.0M | 1.44% | -- | 2026-06-30 |
